Post hoc analysis of coronary findings from the prospective randomized evaluation of the vascular effects of the Norvasc trial (PREVENT).
Mancini
G B John
GB
Vancouver Hospital, Vancouver, BC, Canada. mancini@interchange.ubc.ca
Miller
Michael E
ME
Evans
Gregory W
GW
Byington
Robert
R
Furberg
Curt D
CD
Pitt
Bertram
B
D017311:Amlodipine / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000517:prevention & control*; D003327:Coronary Disease / Q000188:drug therapy*; D023903:Coronary Restenosis; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D002121:Calcium Channel Blockers; D017311:Amlodipine